Drugs / Connettivina
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05805917 Comparator | Apr → Sep 2023 | skin disorder | Istituto Ganassini S.p.A. di Ricerche Biochimiche | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Connettivina | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05805917 ↗ |
| Route | Topical | “Connettivina 0.2% Cream will be applied twice daily, to cover the entire cutaneous surface interested by burns” NCT05805917 ↗ |